Evercore ISI lowered the firm’s price target on McKesson (MCK) to $950 from $1,000 and keeps an Outperform rating on the shares as the firm made several price target adjustments and additions to the firm’s Tactical call lists as part of the firm’s healthcare technology and distribution preview for Q1. Among the changes, the firm added McKesson to its “Tactical Underperform” list.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MCK: